For: | Yang T, Chao K, Zhu X, Wang XD, Chan S, Guan YP, Mao J, Li P, Guan SX, Xie W, Gao X, Huang M. Early proactive monitoring of DNA-thioguanine in patients with Crohn’s disease predicts thiopurine-induced late leucopenia in NUDT15/TPMT normal metabolizers. World J Gastroenterol 2024; 30(12): 1751-1763 [PMID: 38617736 DOI: 10.3748/wjg.v30.i12.1751] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i12/1751.htm |
Number | Citing Articles |
1 |
Abhirup Chatterjee, Prateek Bhatia, Saroj K Sinha, Anupam K Singh, Harshal S Mandavdhare, Jimil Shah, Vaneet Jearth, Arpit Sasani, Aravind Sekar, Minu Singh, Usha Dutta, Vishal Sharma. Effectiveness and safety of thiopurines in inflammatory bowel disease patients with NUDT15 polymorphism: a real-world retrospective study. Expert Review of Clinical Pharmacology 2025; 18(3): 175 doi: 10.1080/17512433.2025.2465425
|
2 |
Cai-Yun Long, Ying Huang. Proactive pharmacogenomics in azathioprine-treated pediatric inflammatory bowel disease at a Chinese tertiary hospital. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1558897
|
3 |
Ahmed B. Bayoumy, A. R. Ansari, C. J. J. Mulder, K. Schmiegelow, Timothy Florin, N. K. H. De Boer. Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy. Clinical Pharmacokinetics 2024; 63(8): 1089 doi: 10.1007/s40262-024-01393-0
|
4 |
Ahmed Bayoumy Bayoumy, Ludovicus Jozef Johannes Derijks, Nanne Klaas Hendrik de Boer. DNA-Thioguanine (DNA-TG) Is a Promising Novel Method to Predict Adverse Events to Thiopurine in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2025; 31(2): 612 doi: 10.1093/ibd/izae234
|